South Korean Olympic table tennis team player Lee Sang-su receiving the first dose of the Pfizer/BioNTech Covid-19 coronavirus vaccine in Seoul (Chung Sung-Jun/Pool Photo via AP Images)

May 6, 2021 08:13 AM EDTUpdated 10:49 AM

Covid-19 roundup: Pfizer/BioNTech donate their vaccine to the Tokyo Olympics; Novavax, Pfizer/BioNTech vaccines appear to be less effective against variants

Josh Sullivan

Nicole DeFeudis

Editor

The long-delayed 2020 Olympics in Tokyo will feature gymnast Simone Biles in what is likely her last Summer Games, and skateboarder Nyjah Huston in what …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Covid-19 roundup: Pfizer/BioNTech donate their vaccine to the Tokyo Olympics; Novavax, Pfizer/BioNTech vaccines appear to be less effective against variants

Josh Sullivan

Nicole DeFeudis

Editor

Sign up to read this article for free.

Applied Therapeutics' rare disease drug gets a CRL

FDA is looking into hematology risks after patients take Bluebird's Skysona gene therapy

Novartis to cut 139 jobs in NJ as part of commercial refocus

PTC reports Phase 2 ALS fail, sells priority review voucher for $150M

Advanz Pharma faces revocation of European authorization for liver disease drug Ocaliva

Idorsia eyes layoffs, tees up Tryvio licensing deal to extend cash runway

Covid-19 roundup: Pfiz­er/BioN­Tech do­nate their vac­cine to the Tokyo Olympics; No­vavax, Pfiz­er/BioN­Tech vac­cines ap­pear to be less ef­fec­tive against vari­ants

Editor

Sign up to read this article for free.

more like this

Covid-19 roundup: Pfizer/BioNTech donate their vaccine to the Tokyo Olympics; Novavax, Pfizer/BioNTech vaccines appear to be less effective against variants